Skip to main content
. 2009 Apr 9;20(2):343–350. doi: 10.1111/j.1750-3639.2009.00283.x

Figure 6.

Figure 6

Quantitative comparisons of MC‐1, ZnT‐1 and ZnT‐6 immunostaining in preclinical stage of Alzheimer's disease (PCAD) and normal control (NC) hippocampus/parahippocampal gyrus brain sections. MC‐1 and ZnT‐6 were significantly increased, and ZnT‐1 was significantly decreased in PCAD (P < 0.05) compared to age‐matched NC subjects.